Xilio Therapeutics, Inc 10-Q for FY2026 Q2
Xilio Therapeutics, Inc. (XLO)
10-Q
2026-08-12
For: 2026-06-30
View Original
Added on
August 13, 2026
About this 10-Q
Xilio Therapeutics, Inc filed this 10-Q on August 12, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $18.69M
- up 131.2% from $8.08M a year earlier
- Net loss
- $6.37M
- compared with a net loss of $15.84M a year earlier
- Diluted EPS
- -$0.33
- compared with -$2.30 a year earlier